ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 87 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $75,000 | -1.3% | 44,086 | +117.7% | 0.00% | – |
| Q4 2021 | $76,000 | -90.8% | 20,249 | -87.3% | 0.00% | – |
| Q3 2021 | $822,000 | +213.7% | 159,130 | +158.3% | 0.00% | – |
| Q2 2021 | $262,000 | +43.2% | 61,596 | +78.5% | 0.00% | – |
| Q1 2021 | $183,000 | -64.0% | 34,515 | -63.5% | 0.00% | – |
| Q4 2020 | $509,000 | +0.6% | 94,473 | +86.7% | 0.00% | – |
| Q2 2020 | $506,000 | +201.2% | 50,600 | +238.5% | 0.00% | – |
| Q1 2018 | $168,000 | – | 14,947 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $2,341,000 | 3.33% |
| Matrix Capital Management Company, LP | 38,974,185 | $66,256,000 | 1.50% |
| NEA Management Company, LLC | 17,082,612 | $29,040,000 | 1.49% |
| Endurant Capital Management LP | 1,824,065 | $3,101,000 | 1.09% |
| Long Focus Capital Management, LLC | 4,679,491 | $7,955,000 | 0.83% |
| Key Client Fiduciary Advisors, LLC | 416,166 | $707,000 | 0.69% |
| PFM Health Sciences, LP | 9,109,780 | $15,487,000 | 0.59% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $153,000 | 0.21% |
| DAFNA Capital Management LLC | 351,064 | $597,000 | 0.16% |
| Rock Springs Capital Management LP | 2,357,544 | $4,008,000 | 0.12% |